Evidence map›Paper›PMID 38180493›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2024

The role of artificial intelligence in informed patient consent for radiotherapy treatments-a case report.

M Moll, G Heilemann, Dietmar Georg, D Kauer-Dorner, P Kuess

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Article
  6. Principles of artificial intelligence in radiooncology.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M MollDepartment of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria. matthias.moll@meduniwien.ac.at.ORCID 0000-0001-5523-8866
G HeilemannDepartment of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-7461-3956
Dietmar GeorgDepartment of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-8327-3877
D Kauer-DornerDepartment of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
P KuessDepartment of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.ORCID 0000-0003-2961-1692
Comprehensive Cancer Center Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advancements in large language models (LMM; e.g., ChatGPT (OpenAI, San Francisco, California, USA)) have seen widespread use in various fields, including healthcare. This case study reports on the first use of LMM in a pretreatment discussion and in obtaining informed consent for a radiation oncology treatment. Further, the reproducibility of the replies by ChatGPT 3.5 was analyzed. A breast cancer patient, following legal consultation, engaged in a conversation with ChatGPT 3.5 regarding her radiotherapy treatment. The patient posed questions about side effects, prevention, activities, medications, and late effects. While some answers contained inaccuracies, responses closely resembled doctors' replies. In a final evaluation discussion, the patient, however, stated that she preferred the presence of a physician and expressed concerns about the source of the provided information. The reproducibility was tested in ten iterations. Future guidelines for using such models in radiation oncology should be driven by medical professionals. While artificial intelligence (AI) supports essential tasks, human interaction remains crucial.

Indexed as

Artificial IntelligenceBreast NeoplasmsInformed ConsentFemaleHumansMiddle AgedPhysician-Patient RelationsRadiation OncologyAIArtificial intelligenceBreast cancerChatGPTOpenAI

Identifiers

PMID38180493
OpenAlexW4390616164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.